Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

The drug’s effects on cardiovascular and inflammation markers outshined its failure to spur weight loss, analysts wrote.

TGDCA conducted raids at 20 Hyderabad gyms, uncovering illegal sale of anabolic-androgenic steroids and cardiac stimulants ...

In the study, published Tuesday in the journal The Lancet, researchers analyzed more than 58,000 participants to compare 30 ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

The findings suggest weight loss drugs independently affect heart health risks, researchers said. View on euronews ...